Polypeptides impliqués dans la biosynthèse des spiramycines, séquences nucléotidiques codant ces polypeptides et leurs applications

European patent · EP1905833 · Deleted

Register entry

Publication number
EP1905833
Application number
EP07019306
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 8, 2003
Published
Apr 2, 2008
Granted
Aug 12, 2015
Deleted
Oct 8, 2023
Reason
Maximum term reached
IPC classes
C12N 15/52 (2006.01)
C12N 9/00 (2006.01)
C12N 15/63 (2006.01)
C12N 1/21 (2006.01)
C07K 14/36 (2006.01)
C12P 19/62 (2006.01)
*C12R 1/465 (2006.01)
Priority
FR 0212489 08.10.2002
FR 0302439 27.02.2003
US 493490 P 07.08.2003
Divided from
EP03807883
Filing language
French
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 8, 2023

    Maximum term reached

    Published in Swissreg on 08.10.2023

  2. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  3. Aug 12, 2015

    Granted

    Published in Swissreg on 12.08.2015

Parties

Holder

Aventis Pharma S.A.

20, avenue Raymond Aron, 92160 Antony, FR

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)

Centre National de la Recherche Scientifique (CNRS)

3, rue Michel-Ange, 75794 Paris Cedex 16, FR

Inventor

Blondelet-Rouault, Marie-Hélène

91400 Orsay, FR

Dominguez, Hélène

84000 Avignon, FR

Darbon-Rongere, Emmanuelle

78960 Voisins Le Bretonneux, FR

Gerbaud, Claude

93220 Gagny, FR

Gondran, Anne

75014 Paris, FR

Karray, Fatma

91440 Bures sur Yvette, FR

Lacroix, Patricia

94170 Le Perreux, FR

Oestreicher-Mermet-Bouvier, Nathalie

92140 Clamart, FR

Pernodet, Jean-Luc

94230 Cachan, FR

Tuphile, Karine

75013 Paris, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.